[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Tomford et al., 1981 - Google Patents

Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritis

Tomford et al., 1981

View PDF
Document ID
18136798275600080107
Author
Tomford R
Karlinsky M
Buddington B
Alfrey A
et al.
Publication year
Publication venue
The Journal of Clinical Investigation

External Links

Snippet

Dietary phosphorus restriction (PR) prevents uremia in rats with nephrotoxic serum nephritis (NSN). One possible mechanism by which PR could be protective would be through the suppression of parathyroid hormone. To evaluate this possibility two separate protocols …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Tomford et al. Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritis
ANAST et al. Impaired release of parathyroid hormone in magnesium deficiency
Windmueller et al. Biosynthesis of plasma apolipoproteins by rat small intestine without dietary or biliary fat.
Reeve et al. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis
Schersten et al. Relationship between the biliary excretion of bile acids and the excretion of water, lecithin, and cholesterol in man
Ibels et al. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients
Pertsemlidis et al. Regulation of cholesterol metabolism in the dog: I. Effects of complete bile diversion and of cholesterol feeding on absorption, synthesis, accumulation, and excretion rates measured during life
Van Tol et al. High density lipoprotein catabolism before and after partial hepatectomy
Nath et al. Diet and cholesteremia: I. Development of a diet for the study of nutritional factors affecting cholesteremia in the rat
Farah et al. Dose-effect relation of cholestyramine in children and young adults with familial hypercholesterolaemia
Kesäniemi et al. Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin.
AXELROD et al. Malignant somatostatinoma: clinical features and metabolic studies
MORITA et al. Vitamin D toxicosis in cats: natural outbreak and experimental study
HILL et al. Adult respiratory distress syndrome associated with colchicine intoxication
AYALA et al. Acute hyperphosphatemia and acute persistent renal insufficiency induced by oral phosphate therapy
BEN NASR et al. Rapid (10-minute) stimulation of rat duodenal alkaline phosphatase activity by 1, 25-dihydroxyvitamin D3
La Ville et al. Inhibition of cholesterol synthesis reduces low-density-lipoprotein apoprotein B production without decreasing very-low-density-lipoprotein apoprotein B synthesis in rabbits
Carlson et al. A case of massive hypertriglyceridemia corrected by nicotinic acid or nicotinamide therapy
Herlihy et al. Effects of Aloe vera ingestion in the rat. I. Growth, food and fluid intake and serum chemistry
Toda et al. Vasculotoxic effects of dietary testosterone, estradiol, and cholesterol on chick artery
Zilversmit et al. Role of the liver and intestine in the turnover of plasma phosphatides in the rat
GOLDMAN et al. Growth hormone stimulation of fatty acid utilization by adipose tissue
Kagami et al. Specific binding of high density lipoprotein (HDL3) is not related to sterol synthesis in rat intestinal mucosa.
Oates et al. Pancreatic blood flow in the rat during enlargement, involution, and cholecystokinin treatment
Ritland et al. Effect of Treatment with a Bile-sequestering Agent (Secholex®) on Intestinal Absorption, Duodenal Bile Acids, and Plasma Lipids